The cholinergic system has been widely implicated in cognitive processes and cholinergic loss is a classical hallmark in Alzheimer disease. Increasing evidence supports a role of the serotonergic system in cognition, possibly through a modulation of cholinergic activity. We compared selective cholinergic denervation by administration of the immunotoxin 192 IgG-saporin in the nucleus basalis of Meynert (NBM) with intracerebroventricular (ICV) lesions of the basal forebrain in male rats 7 days after lesioning. NBM lesions induced significant changes in cholinergic markers in the frontal cortex, whereas ICV lesions produced significant decreases in cholinergic markers both in the frontal cortex and hippocampus. Only ICV lesions lead to memory impairments in passive avoidance and Morris water maze tasks. Both models lead to reductions of serotonin levels in the frontal cortex. Similar changes in 5-hydroxytriptophan levels were observed, suggesting a downregulation of the rate-limiting enzyme for the synthesis of serotonin along with the cholinergic deficit. Neither 5-HT 1A nor 5-HT 1B receptors seem to mediate this process. These data imply that the serotonergic system in the frontal cortex can compensate for diminished cholinergic function and support the investigation of the serotonergic system as a therapeutic target to treat Alzheimer disease.
INTRODUCTION
Alzheimer disease (AD), the most common cause of dementia among elderly people, is characterized by a progressive decline of memory function and behavioral disorders. Senile plaques, neurofibrillary tangles, and cholinergic dysfunction are major hallmarks of the disease, and although the number of tangles correlates better than the number of amyloid plaques with the severity of dementia, the best statistical correlations occur between synaptic density and degree of dementia (1) . In this sense, cholinergic cell loss in the basal forebrain seems to be a better predictor of clinical dementia in AD than plaques and tangles (2, 3) . On the other hand, increasing evidence supports the role of the serotonergic system in learning and memory processes (4) , and biochemical and anatomic studies have shown a functional interaction between serotonergic and cholinergic systems (5Y8). Therefore, serotonergic receptors could modulate the activity of the cholinergic system to cooperate in the regulation of cognitive processes. In animal studies, a combined blockade of the cholinergic and serotonergic systems contributes to a severe and widespread deterioration of adaptive behavior, a condition that might be considered analogous to dementia in man (9) . In fact, extensive serotonergic denervation has been described in AD (7, 10) , although is not yet fully understood whether these changes are a cause or consequence of the cholinergic deafferentation in the illness.
As a result of the limited success of available therapeutic approaches to treat AD, different animal models have been developed to study the process of cortical cholinergic dysfunction as well as new therapeutic strategies. Lesions of the cholinergic neurons in the basal forebrain of rodents, especially of the nucleus basalis of Meynert (NBM; origination point of the cholinergic innervation to cortex) or the medial septum (which provides the major cholinergic input to the hippocampus), have been the most used methods for obtaining these models (11) . Transection of the fimbriaYfornix, glutamate analog excitotoxins (e.g., ibotenic or kainic acid), or aflatoxin AF64A, a choline high-affinity transport inhibitor, have been widely used to induce cholinergic hypofunction, although the lack of selectivity of these techniques also leads to denervation of other neuronal populations located in close proximity to the lesioned area.
Among the available possibilities, 192 IgG-saporin is widely accepted as the most convenient tool to induce selective cholinergic denervation (12, 13) . However, although significant cholinergic damage has been described after 192 IgG-saporin lesions into the NBM, only modest deficits in mnemonic tasks have been reported (14, 15) . One possible reason for the unexpectedly modest effect of 192 IgG-saporin NBM lesions may be the lack of involvement of the frontal cortex in cognitive processes. The possible existence of compensatory mechanisms after the lesions has also been suggested (16, 17) . With these questions in mind and to further characterize the role of the cholinergicYserotonergic relationship in the context of cholinergic loss, as seen in AD, in the present study, we have assessed the effects on the serotonergic system of a selective cholinergic lesion of the NBM with 192 IgG-saporin. Moreover, we have further studied the contribution of the frontal cortex to cognitive processes by comparing the effects of a local selective lesion of the NBM with an intracerebroventricular (ICV) administration of the toxin known to induce both cortical and hippocampal cholinergic denervation. The postlesion time explored was 7 days because previous work shows that cholinergic denervation is completely established by this time (18, 19) . Male Wistar rats (Charles River Laboratories, Inc., Wilmington, MA) weighting 250 g at the beginning of the study were kept at constant room temperature (21 T 1-C) and relative humidity of 55% T 5% with a 12-hour light/dark cycle and ad libitum access to food and water. All experiments were carried out following the recommendations of the EU (DOCE L 358/1 18/2/1986) for the use of laboratory animals.
MATERIALS AND METHODS

Drugs and Animals
Production and Characterization of Lesions
Partial cholinergic lesions were performed, as previously described, to obtain decreases in cholinergic markers similar to those previously described in AD (7) . The immunotoxin 192 IgG-saporin was infused bilaterally into the NBM (0.067 Kg/KL per hemisphere) (15) or ICV (1 Kg/KL per hemisphere) (20) . Sham groups received equal amounts of saline. Postlesion survival times were established at 7 and 90 days.
To asses the extent and selectivity of the lesion, acetylcholinesterase (AChE) activity and high-affinity choline uptake (HACU) were determined in duplicate or triplicate in the frontal cortex and hippocampus as described (6) . Total ACh levels were determined using high-performance liquid chromatography (HPLC) with electrochemical detection. ACh content was calculated by comparing with a 1 pmol standard. The sensitivity limit was 50 fmol.
Microdialysis Studies
Microdialysis probes were implanted into the right frontal cortex at the specified time point (7 days) after NBM lesions. Coordinates were as follows: +3.2 mm AP, 0.5 mm ML, and j3.5 mm DV. The dialysis probe has a diameter of 250 Km and the exposed dialysis membrane of 3 mm (Cuprophan; Applied Neuroscience, London, UK). Dialysis experiments were conducted 24 hours after probe implantation surgery. The probes were perfused at a constant flow rate of 1.0 KL/minute using a microperfusion pump (CMA, Stockholm, Sweden) with cerebrospinal fluid containing NaCl 120 mM, KCl 1.4 mM, MgCl 2 1.2 mM, CaCl 2 0.83 mM, and NaHCO 3 20 mM in phosphate buffer (1.3 mM, pH 7.4). The acetylcholinesterase inhibitor neostigmine bromide (1 KM) was added to the perfusion solution to prevent ACh degradation. Dialysate was discharged during the equilibration period (120 minutes) and then collected every 30 minutes. After collection of 3 baseline fractions, KCl 100 mM was infused for 30 minutes and 4 more postbasal fractions were collected afterward. ACh content was determined using HPLC as described previously.
Serotonin Levels
Total 5-HT levels were determined in duplicate using HPLC with electrochemical detection as previously described (7).
5-HT Immunohistochemistry
Immunocytochemistry was carried out using monoclonal antibodies specific for 5-HT in free-floating sections corresponding to the frontal cortex and raphe as previously described (21) . Sections were developed with diaminobenzidine and hydrogen peroxidase.
Tryptophan-5-Hydroxylase Activity
The in vivo activity of tryptophan-5-hydroxylase (TPH), the rate-limiting enzyme in the pathway for the synthesis of 5-HT, was determined in duplicate by measuring the accumulation of 5-hydroxytryptophan (5-OH tryptophan) within 30 minutes after inhibition of the aromatic L-amino acid decarboxylase by a maximally effective dose of 3-hydroxybenzylhydrazine HCl (NSD), 100 mg/kg intraperitoneally. The 5-OH tryptophan formed was determined by HPLC with electrochemical detection (22) .
Binding Studies to 5-HT 1A and 5-H 1B/D Receptors
All the determinations were performed in duplicate. Data were subjected to Scatchard analysis to determine the number of binding sites (Bmax: fmol/mg of protein) and the dissociation constant (Kd:nM). The amount of protein in each tissue was assessed according to the Bradford method (23).
Frontal cortex was homogenized in ice-cold Tris-HCl buffer 50 mM (pH 7.7) and centrifuged at 49,000 g for 15 minutes at 4-C. The pellet was resuspended in the same buffer and incubated at 37-C for 15 minutes. After a second centrifugation in the same conditions, the resultant pellet was resuspended in buffer containing 4 mM CaCl 2 for 5-HT 1A receptors and 4 mM CaCl 2 , 0.1% ascorbic acid, and 10 KM pargyline for 5-HT 1B/1D receptors. 5-HT 1A binding was performed according to the procedures previously described (24) with minor modifications. Tubes containing 100-KL tissue suspension, 50 KL of [ 3 H] 8-OH-DPAT (0.4Y2 nM), and 50 KL of incubation buffer with or without buspirone 10 KM were incubated for 15 minutes at 37-C. 5-HT 1B/1D binding was performed as previously described (25) 
Passive Avoidance
A 2-compartment passive avoidance apparatus was used (26) . The apparatus consisted of an illuminated white compartment (42 Â 44 Â 46 cm) and a dark compartment (15 Â 15 Â 30 cm) separated by a guillotine door and equipped with an electrified grid (model 1516; Letica, Barcelona, Spain). In the acquisition phase, the rat was placed in the illuminated area and 3 seconds later, the door was raised. The animal explored the apparatus freely for 90 seconds and when the rat entered the dark chamber, the guillotine door was closed again. After 10 seconds, an inescapable 2-mA scrambled electrical foot shock was delivered for 3 seconds through the grid. A retention trial was given 24 hours later by placing the rat in the illuminated compartment and measuring the latency to reenter the dark compartment for a maximum time of 180 seconds. Results were expressed as mean retention latency for each group of rats.
Morris Water Maze
The water maze procedure was adapted from that described originally (27) . The maze consisted of a black circular tank (140 cm in diameter Â 55 cm high) filled with water at 20 T 1-C. The pool was virtually divided into 4 equal quadrants identified as northeast, northwest, southeast, and southwest. A black invisible platform, 10 cm in diameter, was located in a constant position in the middle of the southwest quadrant. The water level was 1 to 2 cm above the platform, which was completely concealed. The pool was surrounded by white curtains marked with black geometric paintings for extramaze clues for the animals. The information was analyzed using Ethovision 3.0 (Noldus Information Technology B.V., Wageningen, The Netherlands).
On the first day, the animals performed a single trial of 120 seconds without the platform present to get used to the pool. In the acquisition phase, rats performed 6 training trials per day for 2 consecutive days (days 2 and 3) with the escape platform in a fixed position in the southwest quadrant. Trials were started by placing the animals facing the wall at starting points designated as north, south, east, and west. Rats were allowed to swim until they found the platform or until 120 seconds elapsed. If it was unable to find the platform within 120 seconds, it was then placed on the platform for 15 seconds and a maximum score of 120 seconds was assigned. Latencies and lengths to find the platform were recorded and speed was calculated as the quotation length/latency. On day 4 (retention phase), a single transfer test was performed in which the platform was removed from the tank. Rats were allowed to swim for 60 seconds in search of the platform. The time spent by the animals in the southwest quadrant (where the platform was located during the acquisition phase) was recorded and data were expressed as percentage of time in the selected quadrant.
Statistical Analysis
The effect of the lesion on cholinergic markers (AChE, HACU, total ACh), total 5-HT levels, 5-OH-tryptophan, 5-HT 1A and 5-HT 1B/1D receptors densities, and passive avoidance were determined by one-way analysis of variance followed by Tukey B or Tamhane test. Microdialysis experiments and Morris water maze were assessed using 2-way analysis of variance with time as repeated measure followed by Tukey B test. NBM or ICV sham and control groups did not differ in any of the experiments and therefore they were considered a single population in all performed comparisons.
RESULTS
Cholinergic System
As summarized in the Table, both NBM and ICV cholinergic lesions with 192 IgG-saporin caused an overall reduction of cholinergic markers in the frontal cortex that reached 40% for AChE or 30% to 35% for HACU in all lesioned animals. Total ACh content was also reduced by 50% to 60%. When hippocampus was assessed, similar reductions were observed for ICV-lesioned animals, whereas no statistical changes were detected for NBM-lesioned animals.
Basal ACh levels 7 days after a NBM lesion were nondetectable compared with control and sham levels 
Effects of Lesions on Learning and Memory Processes
Passive avoidance studies showed that only ICVlesioned animals were significantly impaired, because 24-hour retention latency was significantly reduced 7 days after the lesion. No differences were observed for NBM lesions at any postsurgical time under study when compared with control and sham animals (Fig. 1) .
Similarly, when lesioned animals were analyzed in the Morris water maze test, only ICV-lesioned animals showed significant learning and memory dysfunction both in the acquisition and in the retention phase of the test (Figs. 2 and 3) . ICV-lesioned animals showed significantly higher latencies to FIGURE 1. Effects on learning and memory processes in the passive avoidance test 7 (IgG 7) days after a selective lesion with 192 IgG-saporin in the nucleus basalis of Meynert (NBM) and intracerebroventricular (ICV) lesions. Data are presented as means T standard error of mean from 8 to 18 animals. Acquisition (shock latency) showed no differences (F 3,75 = 2.581; p = 0.06). Retention (24-hour latency) differences were determined by one-way analysis of variance followed by Tamhane test (F 3,72 = 9.034; *, p G 0.01 vs control, sham, and NBM lesions). Acquisition and retention differences were determined by Student t test for paired samples and statistical significances were detected for control, sham, and NBM lesions (IgG 7) ( †, p G 0.01 vs basal levels). find the hidden platform over the 12 trials of the acquisition phase. In the retention phase, only ICV-lesioned animals showed significantly shorter times in the quadrant where the platform was located during the acquisition phase (i.e. southwest quadrant), whereas NBM-lesioned animals did not show memory impairment during the retention phase. Swim speed was not affected by lesions in either acquisition or retention phase (data not shown).
Serotonergic System
Total 5-HT cortical levels (Fig. 4) showed a significant reduction in NBM-and ICV-lesioned animals 7 days after the lesions compared with control and sham values. When 5-HT levels were measured in the hippocampus, no statistical differences were observed between any of the groups under study.
Immunohistochemical studies showed marked decreases in 5-HT labeled terminals in lesioned animals. However, serotonergic neurons in the raphe did not seem to be affected by the lesion (Fig. 5) .
Binding studies showed that 5-HT 1A receptor densities were not affected by the selective cholinergic lesion of the NBM with 192 IgG-saporin at any postsurgical time (Bmax = 139.50 T 6.62, 121.42 T 9.61, and 104.60 T 14.02 fmol/mg protein for controls, sham, and 7 days after a NBM lesion, respectively [F 2,15 = 3.482; *, p = 0.057]). 5-HT 1B/1D receptor densities were not affected either (Bmax = 123.00 T 8.61, 109.62 T 4.82, and 122.83 T 5.02 fmol/mg protein for controls, sham, and 7 days after a NBM, respectively [F 2,19 = 1.377; *, p = 0.276]). No differences were observed among the groups under study when the dissociation constants were measured for 5-HT 1A or 5-HT 1B/1D (data not shown).
Similar to 5-HT levels, 5-OH tryptophan levels were significantly reduced in the frontal cortex 7 days after both NBM and ICV lesions (Fig. 6) . No statistical differences were detected when 5-OH tryptophan levels were measured in the hippocampus after selective cholinergic lesions (data not shown).
DISCUSSION
Apart from the well-established pathological manifestations in AD such as senile plaques and tangles, extensive evidence supports the early and massive dysfunction of the cholinergic system associated with the illness, and changes in cholinergic markers have been closely related to cognitive impairment in AD (7, 23, 28, 29) . Consequent to the cholinergic hypothesis of dementia, animal studies have been used to evaluate the role of cholinergic neurotransmission in learning and memory, and selective lesion of cholinergic neurons remains a widely used method to mimic some aspects of neurodegeneration in AD (30) .
As expected, the cholinergic lesion of the NBM with 192 IgG-saporin yielded significant reductions in cholinergic markers, AChE, HACU, total tissular ACh content, and basal extracellular ACh levels in the frontal cortex without appreciable changes in the hippocampus as previously described (31Y33). ICV administrations lead to similar reductions in the cortex, but the hippocampus was also affected, assuring the anatomic selectivity of the lesions performed. Basal extracellular ACh levels were nondetectable 7 days after the lesion. A highly depolarizing stimulus, KCl 100 mM, known to produce a maximal ACh release both in young or aged rats (34) or after a cholinergic lesion (35) , was able to significantly increase ACh release, suggesting that the cholinergic neurons that remained after the lesion, although their activity was undetectable in baseline conditions.
When we assessed the effect of the cholinergic lesions on learning and memory processes, we observed that only when both the frontal cortex and hippocampus experience a cholinergic deafferentation (by ICV administration of the toxin) were cognitive deficits detected as shown by 2 different cognitive tests (passive avoidance and Morris water maze). No significant loss of Purkinje cells resulting from the cholinergic lesion was suspected because no motor deficit as measured by swim speed in the Morris water maze was observed. The selective lesion of the NBM did not provoke cognitive deficits and similar lack of effect on of cognitive processes has been observed for cholinergic lesions that selectively affect the medial septum/diagonal band of Broca with 192 IgG-saporin (36, 37) , although memory deficits depend on the studies and methods used (38) . Wrenn et al showed that only ICV administration of 192 IgG-saporin, which guarantees both NBM and medial septum cholinergic removal, can induce learning and memory problems (39) . After these results, it has been shown that spatial memory does not depend on the integrity of medial prefrontal cortex (16, 17) . It has also been suggested that the cholinergic basal forebrain may not play a significant role in spatial working memory (40) and that ACh in the frontal cortex is important for egocentric but not allocentric (like in our case) spatial memory (41) . Also, unlike their relative lack of effect on cognition, cholinergic lesions of the NBM may disrupt some aspects of attention (42, 43) . On the other hand, it is also worth considering that in conditions of partial lesion, like in our case, the cholinergic system could compensate for a certain amount of neuronal damage before cognitive problems are detectable. Therefore, a feasible explanation would implicate other neurotransmitter systems that, modulating cholinergic activity, could compensate for the lack of cholinergic innervation. Supporting this argument, fimbriaYfornix lesions, known to interrupt cholinergic and noncholinergic inputs from the septum to the hippocampus, produced learning impairments in the Morris water maze (44) . The serotonergic system has been implicated in learning and memory processes (4) , and previous studies have assessed the capacity of the serotonergic system to modulate the cholinergic activity (6, 7, 45) . Damage of either cholinergic or serotonergic system alone has little effect on cognitive status of rats, but combined damage to both systems is reported to produce memory impairments (20) or, even more, a status similar to dementia in humans (46) . Although extensive studies have underlined the close anatomic (47) and physiological (48, 49) relationship between the cholinergic and serotonergic systems, the interactions between ACh and 5-HT seem to be extremely complicated. Myhrer has pointed out that the multiple memory systems in the rat brain can hardly be related to specific transmitter systems because of the great extent of interactions between the systems (50) . Therefore, we explored the possible effects of a selective cholinergic lesion on the serotonergic system. Previous studies with ICV cholinergic lesions have shown no change in cortical 5-HT levels with reductions of approximately 40% in 5-HIAA at 7 days (51), increased cortical 5-HT and 5-HIAA levels 90 days after the lesion (52), or no changes at all (53) . We observed significant reductions in total 5-HT levels in the frontal cortex of lesioned animals both after NBM and ICV lesions. It does not seem probable that the changes are the result of a lack of selectivity of the immunotoxin as previous studies have already assessed the extremely high selectivity of 192 IgG-saporin at the dosages used in this study (54, 55) ; moreover, no serotonergic alterations were detected in the hippocampus or raphe, supporting the specificity of the changes. Because 5-HT has an overall inhibitory effect on cortical ACh release (56, 57) , it is possible that, after cholinergic denervation, a serotonergic inhibition would compensate for cholinergic deficits, allowing a higher stimulation of the remaining cholinergic neurons. Supporting this idea, in our hands, decreased 5-HT levels were observed 7 days after the administration of the immunotoxin. It is possible that changes in cortical serotonergic levels would help to compensate for reduced cholinergic function, therefore preventing the purported cognitive impairments after an NBM lesion. However, in the hippocampus, these compensatory changes in 5-HT levels do not seem to occur, and cholinergic ICV lesions affecting this area may lead to cognitive impairments.
As to the mechanisms responsible for these changes in 5-HT levels, we determined the densities of both 5-HT 1A and 5-HT 1B/1D receptors in the frontal cortex. These receptors were chosen because: 1) both receptors have been widely implicated in learning and memory processes; 2) autoreceptors modulate 5-HT release (58, 59) ; and 3) heteroreceptors can modulate ACh release (5, 60, 61) . However, in our hands, neither of these receptors seemed to be implicated in the changes observed in the 5-HT levels, because their density was not affected by the lesion. It can also be hypothesized that the serotonergic synthesis may be downregulated to compensate for the cholinergic dysfunction. Supporting this idea, we found reductions in cortical 5-OH tryptophan levels 7 days after both ICV and NBM lesions, showing a modulation of amino acid decarboxylase activity, the limiting step in 5-HT synthesis. The lack of effect on cortical, not hippocampal, serotonergic levels may be the result of the fact that serotonergic innervation to the frontal cortex is provided by the dorsal raphe nucleus, whereas the serotonergic innervation of the hippocampus is provided by the dorsal and medial raphe nuclei (62) and therefore 5-HT synthesis may be modulated in a different way depending on the origin of the innervation.
In summary, after a selective lesion of the basal forebrain, compensatory serotonergic mechanisms help to restore diminished cholinergic function. In fact, an imbalance between cholinergic and serotonergic systems has been described to be responsible for the cognitive impairment associated with AD (7). The knowledge of the relationship between the serotonergic and cholinergic systems in situations of cholinergic hypofunction such as seen in AD will help the development of new rational therapeutic approaches to the illness. Our results suggest that, apart from the available cholinomimetic therapies to treat AD, other efforts should be directed toward targeting other neurotransmitter systems, particularly the serotonergic system.
